-
Product Name
Cynomolgus Erythropoietin / EPO (His Tag) recombinant protein
- Documents
-
Description
Erythropoietin is a member of the EPO / TPO family. It is a secreted, glycosylated cytokine composed of four alpha helical bundles. Erythropoietin can be found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. It also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types. Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass. It is produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals. Genetic variation in erythropoietin is associated with susceptbility to microvascular complications of diabetes type 2. These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. It has a longer circulating half-life in vivo. Erythropoietin is being much misused as a performance-enhancing drug in endurance athletes.
-
Protein short names
EP; OTTMUSP00000024624; MVCD2; MGC138142; ERYTHROPOIETIN; EPO; OTTMUSP00000024626; OTTMUSP00000024625
-
Source/Expression Host
Human Cells
-
Expression Plasmid/cDNA
A DNA sequence encoding the cynomolgus Epo (XP_005549312.1) (Met1-Arg192) was expressed with a polyhistidine tag at the C-terminus.
-
Protein Species
Cynomolgus
-
Molecular weight
The recombinant cynomolgus Epo consists 176 amino acids and predicts a molecular mass of 19.7 kDa.
-
Purity
> 95 % as determined by SDS-PAGE.
-
Activity
Measured in a cell proliferation assay using TF-1 human erythroleukemic cells.
The ED50 for this effect is typically 0.4-2 ng/mL. -
Validations
Cynomolgus Erythropoietin / EPO Protein (His Tag) SDS-PAGE
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"